The HCV Advocate salutes the Veterans Administration for their response to identifying and treating veterans infected with hepatitis C. Click here to read the article
Abstract: Hepatitis C care in the Department of Veterans Affairs: Building a foundation for success – P. S. Belperio, et. al.
Source: Infect Dis Clin N Am 32 (2018) 281–292
Summary: The Veterans Affairs (VA) is the largest medical provider for patients infected with hepatitis C in the United States. The VA estimates that 8.4% U.S. of veterans are infected with hepatitis C and have diagnosed 90% of veterans. An estimated 8,000-10,000 veterans remain undiagnosed. HCV treatment in the VA is available through an innovative approach that uses clinical pharmacists, nurse practitioners, physician assistants, video telehealth medicine and various electronic technologies. Maximum patient co-pay costs are $33.00 for a 12-week supply. The co-pay cost may be waived depending on the patient’s financial situation. As of December 2017, the VA has treated 100,000 veterans infected with hepatitis C.